STONY BROOK UNIVERSITY
LATEST UPDATES
2011 SPONSORS
LEADERSHIP COUNCIL
SPECIAL EVENT SPONSOR
PLATINUM SPONSORS
JOIN KEY OPINION LEADERS from industry, academia, medical research foundations, and other major stakeholders who share the goal of bringing new and better therapeutic options to patients faster. The Life Sciences Summit 2012 will explore new paradigms, examine barriers, and think about realigning legacy mind-sets toward a more efficient and productive drug development enterprise. The Program features more than forty-five emerging companies and fifty breakthrough technologies that collectively represent the future of the industry.
PROGRAM HIGHLIGHTS
Emerging Company & Innovators Showcase featuring more than forty next-generation industry leaders including Andarix, Kalos, BREONICS, Acceleron, TechnoVax, Vybion… (more)
Plenary Sessions featuring George Scangos, CEO, Biogen Idec, Shaun Grady, VP Strategic Partnering, AstraZeneca, Greg Wiederrecht, VP, WW Licensing & Ext. Res., Merck, Mary Tanner, Managing Director, Peter J. Solomon Co., Cary Pfeffer, Partner, Third Rock Ventures, Marck Tessier-Lavigne, President, The Rockefeller Univ, Bruce Stillman, President, Cold Spring Harbor Laboratory, Maria Freire, President, Lasker Foundation …(more)
Business Workshops featuring investors and business leaders including Jonathan Fleming, Oxford Bioscience Partners, Louis Berneman, Osage University Partners, Christopher Yochim, Strategic Planning & BD, AstraZeneca, Susan Rohrer, Senior Director, External Scientific Affairs, Merck, Andy Dorner, VP, Millennium…(more)
Translational Research Forum featuring Key Opinion Leaders and academic scientists working in breakthrough areas in oncology, neurology, infectious diseases and regenerative medicine. Arturo Casadevall, Albert Einstein COM, Warren Strittmatter, Duke, Howard Scher, MSKCC, Arnold Caplan, Case Western, …(more)
Collaborate™, an on-line & on-site partnering service to foster new business opportunities, partnerships, and collaborations. Register for the Summit and let the deals begin!
Michael Barbachyn, PhD, Head of External Science, AstraZeneca Pharmaceuticals
Anthony Caggiano, MD, PhD, Vice President, Preclinical Development, Acorda Therapeutics
Arnold Caplan, PhD, Professor of Biology, Professor of General Medical Sciences (Oncology),
Case Western University
Arturo Caplan, PhD, Professor, Chair, Department of Microbiology & Immunology, Department of Medicine, Albert Einstein College of Medicine
Stephen Chang, PhD, New York Stem Cell Foundation
Eva Chmielnicki, PhD, Senior Editor, Research Manuscripts, Nature Medicine
Min Cho, PhD, Associate Editor, Nature Neuroscience
Alonzo D. Cook, PhD, Manager, Technology Assessment, Advanced Technologies and Regenerative Medicine, LLC (ATRM) Johnson & Johnson
Louis J. DeGennaro, PhD, Chief Mission Officer, Executive Vice President, Leukemia and Lymphoma Society
Sheng Ding, PhD, Assistant Professor, Department of Chemistry, Scripps Research Institute
Andy Dorner, PhD, Vice President, Millennium Pharmaceuticals
Howard Fillit, MD, Executive Director, Alzheimer's Drug Discovery Foundation
Gunda Georg, PhD, Professor and Head, Department of Medicinal Chemistry, Director, Institute for Therapeutics Discovery & Development, University of Minnesota
Demetrios L. Kouzoukas, Of Counsel, Covington & Burling LLP
Ram May-Ron, Vice President, FreeMind Group
Jules Mitchel, PhD, President, Target Health Inc.
Iwao Ojima, PhD, Distinguished Professor of Chemistry, Director, Institute for Chemical Biology and Drug Discovery, Stony Brook University
Brock Reeve, MPhil, MBA, Executive Director, Harvard Stem Cell Institute
Susan Rohrer, PhD, Senior Director, External Affairs, Merck & Co., Inc.
Eric K. Rowinsky, MD, Adjunct Professor, New York University
Alan J. Russell, PhD, Founding Director, McGowan Institute for Regenerative Medicine
Edward Saltzman, President, Defined Health
Peter Senter, PhD, Vice President, Chemistry and Distinguished Fellow, Seattle Genetics, Inc.
Andy Shih, PhD, Vice President of Scientific Affairs, Autism Speaks
Barbara S. Slusher, PhD, MBA, Chief Scientific Officer, Brain Science Institute, Johns Hopkins School of Medicine
Bruce Stillman, PhD, President, Cold Spring Harbor Laboratory
Ken Stover, PhD, Senior Director, MedImmune
Marc Tessier-LaVigne, PhD, President and Professor, Laboratory of Brain Development and Repair, The Rockefeller University
Gordana Vunjak-Novakovic, PhD, Professor, Biomedical Engineering, Columbia University
Charles A. Weiss, Partner, Kenyon & Kenyon LLP
Christopher Yochim, Director, Strategic Planning & Business Development, AstraZeneca
